Towards accelerating small molecule drug discovery with pre-trained, late fusion multi-view models
- 2024
- ACS Fall 2024
Elif Eyigoz
Overview
Title
Staff Research Scientist
Location
IBM Research - Yorktown Heights
Yorktown Heights, NY USA
Bio
Elif Eyigoz has a multi-disciplinary background with degrees in Philosophy (BA), Cognitive Science (MA), Linguistics (MA), and Computer Science (MS and PhD), and as a believer of life-long learning, she is currently a graduate student at the department of Statistics at the Columbia University.
After she completed her PhD in Computer Science, she joined IBM in 2014 as a natural language processing (NLP) algorithms developer at Watson Labs, and later joined IBM research in 2016 as a researcher.
Her current research interests include disease progression modeling, drug discovery, and applications of NLP in healthcare.
Publications
Large-scale screening of clinical assessments to distinguish between states in the Integrated HD Progression Model (IHDPM)
- Zhaonan Sun
- Jennifer Ware
- et al.
- 2024
- Front. Aging Neurosci.
DPM360: New Additions to Advanced Disease Progression Modeling
- Akira Koseki
- Italo Buleje
- et al.
- 2022
- OHDSI Collaborator Showcase 2022
Patents
Top collaborators
JH
Jianying Hu
IBM Fellow; Director, Healthcare and Life Sciences Research; Global Science Leader, AI for Health
CT
Ching-Huei Tsou
Senior Research Scientist & Manager, Biomedical Foundation Model / NLP | Accelerated Discovery | HCLS
JM
Joseph Morrone
Research Staff Member - Healthcare & Life Sciences Research